Laron Z. The GH-IGF1 axis and longevity: the paradigm of IGF1 defciency. Hormones. 2008; 7: 24–7.
278
Cawthorne T. Toulouse-Lautrec – triumph over infrmity. Proc Roy Soc Med 1970;63: 800–5.
279
Maroteaux P, Lamy M. The malady of Toulouse-Lautrec. JAMA. 1995; 191:715–17.
280
Maroteaux P. Toulouse-Lautrec’s diagnosis. Nat Genet. 1995; 11:362–3.
281
Frey JB. What dwarfed Toulouse-Lautrec? Nat Genet. 1995; 10:128–30.
282
Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K defciency. Science. 1996; 273:1236–8.
283
Toral-Lopez J, Gonzalez-Huerta LM, Sosa B, Orozco S, Gonzalez HP, Cuevas-Covarrubias SA. Familial pycnodysostosis: identification of a novel mutation in the CTSK gene (cathepsin K). J Investig Med. 2011; 59:277–80.
284
Chen W, Yang S, Abe Y, Li M, Wang Y, Shao J, Li E, Li YP. Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence. Hum Mol Genet. 2007; 16:410–23.
